Quality of Life for Mesothelioma Patients Hinges on Activity and Nutrition

quality of life for mesothelioma

Muscle mass and nutrition can have a direct impact on quality of life for mesothelioma patients. That’s the finding of an Australian study of sixty-one men and women with malignant pleural mesothelioma. Researchers say the quality of life for mesothelioma patients was compromised by lower muscle mass or malnutrition. It is a wake-up call for mesothelioma patients to stay active and eat well for the best outcomes. Impacts on Quality of Life for Mesothelioma Patients Pleural mesothelioma is an incurable cancer. Even with the best mesothelioma treatments, most patients still face a grim prognosis. But there is evidence that good self-care may help. Previous studies have shown that patients with the best nutritional status often have longer mesothelioma survival. Nutritional … Continue reading Quality of Life for Mesothelioma Patients Hinges on Activity and Nutrition »

Chemotherapy During Mesothelioma Surgery: Is it Dangerous?

chemotherapy during mesothelioma surgery

A new study finds that chemotherapy during mesothelioma surgery does not raise the risk for complications. That could be good news for pleural mesothelioma patients who want to keep cancer at bay as long as possible. A group of Indian doctors compared the cases of thoracic cancer patients who had surgery with or without intraoperative chemotherapy. Only one of the “surgery + chemotherapy” patients developed a serious complication. Patients in this group also lived longer than those who did not receive intraoperative chemotherapy. When Do Doctors Use Chemotherapy During Mesothelioma Surgery? The two primary types of mesothelioma surgery are extrapleural pneumonectomy (EPP) or lung-sparing pleurectomy/decortication (P/D). Patients often have chemotherapy prior to surgery to shrink their mesothelioma tumor. Many have … Continue reading Chemotherapy During Mesothelioma Surgery: Is it Dangerous? »

Mesothelioma Survival Factors Revealed by New Study

mesothelioma survival factors

New research from the University of Pittsburgh reveals six primary mesothelioma survival factors. These characteristics appear to separate those who die of mesothelioma within just a few months from those who live much longer. The research focused on 888 cases of pleural or peritoneal mesothelioma listed in a national database. Patients received their mesothelioma diagnosis between 1990 and 2017. The study shows that most mesothelioma survival factors are out of patients’ control. Calculating Mesothelioma Survival Factors Not many people survive mesothelioma long term. It is one of the most aggressive and hard-to-treat types of cancer. By the time mesothelioma patients develop their first symptoms, the asbestos cancer is usually already at an advanced stage. Deciding the best way to treat … Continue reading Mesothelioma Survival Factors Revealed by New Study »

Cancer Centers May Not Manage Mesothelioma Symptoms Adequately, Study Finds

manage mesothelioma symptoms

UK researchers say the number of patients receiving palliative care to manage mesothelioma symptoms may be lagging behind the need. Nottingham University conducted a needs assessment of more than 700 patients over two years. Seventy percent of patients with pleural mesothelioma or another thoracic cancer completed a questionnaire shortly after diagnosis. Their results revealed a high unmet need for palliation to manage mesothelioma symptoms and those of other thoracic malignancies. How Does Palliative Care Help Manage Mesothelioma Symptoms? Palliative care is any kind of care that helps patients manage mesothelioma symptoms. These can be physical symptoms like breathing difficulty or fatigue. Or they can be psychological symptoms like fear and worry. Palliative care to manage mesothelioma symptoms can include things … Continue reading Cancer Centers May Not Manage Mesothelioma Symptoms Adequately, Study Finds »

Predicting Thyroid Disease After Immunotherapy for Mesothelioma

thyroid disease after imminotherapy

Researchers in Italy say it is possible to predict which mesothelioma patients are likely to develop thyroid disease after immunotherapy. They are advising their colleagues to use the technique for better management of malignant mesothelioma. Immune checkpoint inhibitors like Keytruda are improving the outlook for people with asbestos cancer. But immunotherapy is not without risk. Certain people are prone to develop thyroid disease after immunotherapy. If doctors know ahead of time which mesothelioma patients are at risk, they can be better prepared to manage problems later.   Immune Checkpoint Inhibitors and Thyroid Disease after Immunotherapy Pleural mesothelioma is extremely difficult to treat. Immune checkpoint inhibitors have given many mesothelioma patients new hope. Recent studies suggest that some of these drugs … Continue reading Predicting Thyroid Disease After Immunotherapy for Mesothelioma »

Defactinib Fails Again as a Maintenance Therapy for Mesothelioma

patient chemotherapy for mesothelioma

There has been another setback for a drug that showed promise as a maintenance therapy for mesothelioma. Defactinib is a focal adhesion kinase (FAK) inhibitor. FAK is a signaling pathway that allows stem cells to give rise to new cancer cells. The developers of defactinib hoped that FAK inhibition would help keep mesothelioma tumors from growing back after chemotherapy. But a team of international researchers has once again concluded that the drug does not work as a maintenance therapy for mesothelioma. In Search of a Maintenance Therapy for Mesothelioma Malignant pleural mesothelioma is an aggressive cancer that is very hard to treat. Standard chemotherapy drugs like pemetrexed, cisplatin, gemcitabine and vinorelbine can sometimes shrink tumors, but they usually come back. Doctors … Continue reading Defactinib Fails Again as a Maintenance Therapy for Mesothelioma »

Chemotherapy with Alimta: Putting More Gold in the Gold Standard

chemotherapy with Alimta

A new Italian study suggests there may be a more effective way to deliver mesothelioma chemotherapy with Alimta. Chemotherapy with Alimta (pemetrexed) is the gold standard treatment for malignant pleural mesothelioma. But fewer than 40 percent of mesothelioma patients see improvement when they receive the drug by standard infusion. Now, researchers in biotechnology and nanomedicine think they may have found a way around the limits of chemotherapy with Alimta. Tiny particles of gold may be the answer. Why Chemotherapy with Alimta Does Not Always Work Even though most mesothelioma patients receive chemotherapy with Alimta at some point, it is usually only moderately effective. That is because pemetrexed is a highly potent drug that can cause deadly side effects at high doses. … Continue reading Chemotherapy with Alimta: Putting More Gold in the Gold Standard »

Mesothelioma Incidence in the US: The Good News and the Bad News

Mesothelioma incidence

A new study on mesothelioma incidence in the US contains some good news and some bad news. The good news is that the incidence of the asbestos cancer is finally dropping in the US, after years of growth. The bad news is that, if you live in the Northern part of the US, you are more likely to be exposed to the toxin and your mesothelioma risk is higher. The Good News About Mesothelioma Incidence in the US Asbestos is the primary cause of mesothelioma around the globe and in the US. Asbestos is a naturally-occurring mineral that is resistant to fire and corrosion. It was mined at several sites in the US and used in thousands of consumer products … Continue reading Mesothelioma Incidence in the US: The Good News and the Bad News »

Mesothelioma Patient Alert: Study Questions Safety of B12 Supplements

Safety of B12 Supplements Questioned

New research about the safety of Vitamin B12 supplements is raising red flags for mesothelioma patients and those at risk for mesothelioma. A major international study published in the International Journal of Cancer suggests that too much Vitamin B12 in the body may be a cause of lung cancer. The study included researchers from top institutions like Brigham and Women’s Hospital, Harvard Medical School, the University of Pittsburgh, the American Cancer Society, and the National Cancer Institute. Pleural Mesothelioma and Lung Cancer Pleural mesothelioma has a lot in common with lung cancer. It develops in the cells of the membrane around the lungs. As mesothelioma spreads, the membrane becomes less pliable, making it hard for the lungs to expand normally. … Continue reading Mesothelioma Patient Alert: Study Questions Safety of B12 Supplements »

Who Survives Mesothelioma and Why?

mesothelioma survival couple

A new study of National Cancer Institute data aims to better understand who survives mesothelioma and why. Malignant mesothelioma is a highly aggressive cancer of internal membranes. Very few people diagnosed with mesothelioma live longer than 18 months. But researchers around the world are working to change those odds. One important step is to look at the characteristics of those who live longest with the asbestos cancer. NCI Data Shows Who Survives Mesothelioma Scientists at Mount Sinai Medical Center in New York turned to the National Cancer Institute database to get a better picture of who survives mesothelioma. The database contains information reported by mesothelioma doctors from around the country. It includes information about the ages, gender, lifestyle, mesothelioma type, … Continue reading Who Survives Mesothelioma and Why? »

Get your free copy of
“Surviving Mesothelioma” Today!